Horizon Therapeutics Public Limited Company

Символ: HZNP

NASDAQ

116.3

USD

Пазарна цена днес

  • 62.1155

    Съотношение P/E

  • 0.5721

    Коефициент PEG

  • 26.63B

    MRK Cap

  • 0.00%

    Доходност на DIV

Horizon Therapeutics Public Limited Company Структура на управлението

Информация за управлението

ИмеЗаглавие
Mr. Patrick McIlvennySenior Vice President & Chief Accounting Officer
Ms. Tina E. VenturaSenior Vice President & Chief Investor Relations Officer
Mr. Timothy P. WalbertChairman, Pres & Chief Executive Officer
Ms. Keli WalbertExecutive Vice President & Chief Marketing Officer
Mr. Geoffrey M. CurtisExecutive Vice President of Corporation Affairs & Chief Communications Officer
Mr. Sean M. Clayton J.D.Executive Vice President & Gen. Counsel
Dr. Jeffrey W. Sherman F.A.C.P., FACP, M.D.Executive Vice President & Chief Medical Officer
Mr. Aaron L. CoxExecutive Vice President of Fin. & Chief Financial Officer
Ms. Jane GonnermanSenior Vice President of Corporation Devel. & Chief of Staff, Office of the Chief Executive Officer
Mr. Paul W. HoelscherAdvisor
Mr. Andy PasternakExecutive Vice President & Chief Strategy Officer
Dr. Elizabeth H.Z. Thompson Ph.D.Executive Vice President of R&D